Recent News

• 01.11.2026 - Exagen Inc. Announces Select Preliminary 2025 Financial Results
• 10.23.2025 - Exagen Announces Acceptance of Six Abstracts at 2025 American College of Rheumatology Convergence
• 10.21.2025 - Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
• 09.19.2025 - Anderson Schock
• 09.19.2025 - Anderson Schock
• 08.06.2025 - Exagen Inc. to Participate in Third Quarter Investor Conferences
• 08.06.2025 - Exagen Inc. to Participate in Third Quarter Investor Conferences
• 08.06.2025 - Exagen Inc. to Participate in Third Quarter Investor Conferences
• 08.01.2025 - Chas McKhann
• 08.01.2025 - Chas McKhann

Recent Filings

• 11.04.2025 - 8-K Current report
• 11.04.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.04.2025 - EX-99.1 EX-99.1
• 10.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors